Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment.

Pinker K, Chin J, Melsaether AN, Morris EA, Moy L.

Radiology. 2018 Jun;287(3):732-747. doi: 10.1148/radiol.2018172171.

PMID:
29782246
2.

Cosmetic Dermatology Training During Residency: Outcomes of a Resident-Reported Survey.

Champlain A, Reserva J, Webb K, Griffin D, Moy L, Joyce C, Glaser DA, Lawrence N, Lee KC, Antonovich DD, Duffy DM, Kim J, Ozog D, Sobanko J, Alam M, Tung RC.

Dermatol Surg. 2018 May 16. doi: 10.1097/DSS.0000000000001557. [Epub ahead of print]

PMID:
29781906
3.

Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?

Wake N, Chandarana H, Rusinek H, Fujimoto K, Moy L, Sodickson DK, Kim SG.

Magn Reson Imaging. 2018 May 16. pii: S0730-725X(18)30140-1. doi: 10.1016/j.mri.2018.05.007. [Epub ahead of print]

PMID:
29777820
4.

ACR Appropriateness Criteria® Breast Implant Evaluation.

Expert Panel on Breast Imaging:, Lourenco AP, Moy L, Baron P, Didwania AD, diFlorio RM, Heller SL, Holbrook AI, Lewin AA, Mehta TS, Niell BL, Slanetz PJ, Stuckey AR, Tuscano DS, Vincoff NS, Weinstein SP, Newell MS.

J Am Coll Radiol. 2018 May;15(5S):S13-S25. doi: 10.1016/j.jacr.2018.03.009.

PMID:
29724416
5.

Developments in Breast Imaging: Update on New and Evolving MR Imaging and Molecular Imaging Techniques.

Heller SL, Heacock L, Moy L.

Magn Reson Imaging Clin N Am. 2018 May;26(2):247-258. doi: 10.1016/j.mric.2017.12.003. Epub 2018 Feb 21. Review.

PMID:
29622129
6.

Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.

Pinker K, Moy L, Sutton EJ, Mann RM, Weber M, Thakur SB, Jochelson MS, Bago-Horvath Z, Morris EA, Baltzer PA, Helbich TH.

Invest Radiol. 2018 Apr 3. doi: 10.1097/RLI.0000000000000465. [Epub ahead of print]

PMID:
29620604
7.

Canceled MRI-guided Breast Biopsies Due to Nonvisualization: Follow-up and Outcomes.

Pinnamaneni N, Moy L, Gao Y, Melsaether AN, Babb JS, Toth HK, Heller SL.

Acad Radiol. 2018 Feb 22. pii: S1076-6332(18)30030-8. doi: 10.1016/j.acra.2018.01.016. [Epub ahead of print]

PMID:
29478921
8.

Stereotactic Breast Biopsy With Benign Results Does Not Negatively Affect Future Screening Adherence.

Lewin AA, Gao Y, Lin Young LL, Albert ML, Babb JS, Toth HK, Moy L, Heller SL.

J Am Coll Radiol. 2018 Apr;15(4):622-629. doi: 10.1016/j.jacr.2017.12.034. Epub 2018 Feb 9.

PMID:
29433804
9.

What Happens after a Diagnosis of High-Risk Breast Lesion at Stereotactic Vacuum-assisted Biopsy? An Observational Study of Postdiagnosis Management and Imaging Adherence.

Gao Y, Albert M, Young Lin LL, Lewin AA, Babb JS, Heller SL, Moy L.

Radiology. 2018 May;287(2):423-431. doi: 10.1148/radiol.2017171665. Epub 2018 Jan 29.

PMID:
29378151
10.

Associations of County-level Radiologist and Mammography Facility Supply with Screening Mammography Rates in the United States.

Rosenkrantz AB, Moy L, Fleming MM, Duszak R Jr.

Acad Radiol. 2018 Jan 17. pii: S1076-6332(17)30513-5. doi: 10.1016/j.acra.2017.11.023. [Epub ahead of print]

PMID:
29373212
11.

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.

Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA.

J Am Coll Radiol. 2018 Mar;15(3 Pt A):408-414. doi: 10.1016/j.jacr.2017.11.034. Epub 2018 Jan 19.

PMID:
29371086
12.

Do Tumor Shrinkage Patterns at Breast MR Imaging Predict Survival?

Moy L.

Radiology. 2018 Jan;286(1):58-59. doi: 10.1148/radiol.2017171975. No abstract available.

PMID:
29261475
13.

Screening Mammography Utilization and Medicare Beneficiaries' Perceptions of Their Primary Care Physicians.

Rosenkrantz AB, Fleming MM, Moy L, Babb JS, Duszak R Jr.

Acad Radiol. 2018 Apr;25(4):461-469. doi: 10.1016/j.acra.2017.10.023. Epub 2017 Dec 1.

PMID:
29199056
14.

Feasibility analysis of early temporal kinetics as a surrogate marker for breast tumor type, grade, and aggressiveness.

Heacock L, Lewin AA, Gao Y, Babb JS, Heller SL, Melsaether AN, Bagadiya N, Kim SG, Moy L.

J Magn Reson Imaging. 2017 Nov 27. doi: 10.1002/jmri.25897. [Epub ahead of print]

PMID:
29178258
15.

The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic Properties.

Siu T, Brubaker J, Fuller P, Torres L, Zeng H, Close J, Mampreian DM, Shi F, Liu D, Fradera X, Johnson K, Bays N, Kadic E, He F, Goldenblatt P, Shaffer L, Patel SB, Lesburg CA, Alpert C, Dorosh L, Deshmukh SV, Yu H, Klappenbach J, Elwood F, Dinsmore CJ, Fernandez R, Moy L, Young JR.

J Med Chem. 2017 Dec 14;60(23):9676-9690. doi: 10.1021/acs.jmedchem.7b01135. Epub 2017 Dec 4.

PMID:
29156136
16.

Screening for Breast Cancer in Women Age 75 Years and Older.

Lee CS, Moy L, Joe BN, Sickles EA, Niell BL.

AJR Am J Roentgenol. 2018 Feb;210(2):256-263. doi: 10.2214/AJR.17.18705. Epub 2017 Nov 7.

PMID:
29112471
17.

ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer.

Expert Panel on Breast Imaging:, Slanetz PJ, Moy L, Baron P, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lee SJ, Lewin AA, Lourenco AP, Niell B, Stuckey AR, Trikha S, Vincoff NS, Weinstein SP, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 Nov;14(11S):S462-S475. doi: 10.1016/j.jacr.2017.08.037.

PMID:
29101985
18.

ACR Appropriateness Criteria® Breast Cancer Screening.

Expert Panel on Breast Imaging:, Mainiero MB, Moy L, Baron P, Didwania AD, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lee SJ, Lewin AA, Lourenco AP, Nance KJ, Niell BL, Slanetz PJ, Stuckey AR, Vincoff NS, Weinstein SP, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 Nov;14(11S):S383-S390. doi: 10.1016/j.jacr.2017.08.044.

PMID:
29101979
19.

Trends in breast imaging: an analysis of 21years of formal scientific abstracts at the Radiological Society of North America.

Heller SL, Charlie A, Babb JS, Moy L, Gao Y.

Clin Imaging. 2018 May - Jun;49:1-6. doi: 10.1016/j.clinimag.2017.10.018. Epub 2017 Oct 28.

PMID:
29100042
20.

Male Surgical Neck Rejuvenation.

Moy RL, Moy L.

Dermatol Surg. 2017 Nov;43 Suppl 2:S203-S207. doi: 10.1097/DSS.0000000000001347. Review. Retraction in: Dermatol Surg. 2018 Apr;44(4):605.

PMID:
29064986
21.

Harmonizing Breast Cancer Screening Recommendations: Metrics and Accountability.

Lee CS, Moy L, Friedewald SM, Sickles EA, Monticciolo DL.

AJR Am J Roentgenol. 2018 Feb;210(2):241-245. doi: 10.2214/AJR.17.18704. Epub 2017 Oct 18.

PMID:
29045178
22.

Improvement of Actinic Keratoses Using Topical DNA Repair Enzymes: A Randomized Placebo-Controlled Trial.

Stoddard M, Herrmann J, Moy L, Moy R.

J Drugs Dermatol. 2017 Oct 1;16(10):1030-1034.

PMID:
29036257
23.

Intravoxel incoherent motion (IVIM) histogram biomarkers for prediction of neoadjuvant treatment response in breast cancer patients.

Cho GY, Gennaro L, Sutton EJ, Zabor EC, Zhang Z, Giri D, Moy L, Sodickson DK, Morris EA, Sigmund EE, Thakur SB.

Eur J Radiol Open. 2017 Aug 18;4:101-107. doi: 10.1016/j.ejro.2017.07.002. eCollection 2017.

24.

Gender and Subspecialty of Urology Faculty in Department-based Leadership Roles.

Han J, Stillings S, Hamann H, Terry R, Moy L.

Urology. 2017 Dec;110:36-39. doi: 10.1016/j.urology.2017.07.044. Epub 2017 Aug 9.

PMID:
28802569
25.

Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA.

J Am Coll Radiol. 2017 Sep;14(9):1137-1143. doi: 10.1016/j.jacr.2017.06.001. Epub 2017 Jun 22.

PMID:
28648873
26.

Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammation.

Smith GF, Altman MD, Andresen B, Baker J, Brubaker JD, Chen H, Chen Y, Childers M, Donofrio A, Ferguson H, Fischer C, Fischmann TO, Gibeau C, Hicks A, Jin S, Kattar S, Kleinschek MA, Leccese E, Lesburg C, Li C, Lim J, Liu D, Maclean JKF, Mansoor F, Moy LY, Mulrooney EF, Necheva AS, Presland J, Rakhilina L, Yang R, Torres L, Zhang-Hoover J, Northrup A.

Bioorg Med Chem Lett. 2017 Jun 15;27(12):2721-2726. doi: 10.1016/j.bmcl.2017.04.050. Epub 2017 Apr 18.

PMID:
28501511
27.

ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.

Expert Panel on Breast Imaging:, Moy L, Bailey L, D'Orsi C, Green ED, Holbrook AI, Lee SJ, Lourenco AP, Mainiero MB, Sepulveda KA, Slanetz PJ, Trikha S, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 May;14(5S):S282-S292. doi: 10.1016/j.jacr.2017.02.009. Review.

PMID:
28473085
28.

ACR Appropriateness Criteria® Breast Pain.

Expert Panel on Breast Imaging:, Jokich PM, Bailey L, D'Orsi C, Green ED, Holbrook AI, Lee SJ, Lourenco AP, Mainiero MB, Moy L, Sepulveda KA, Slanetz PJ, Trikha S, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 May;14(5S):S25-S33. doi: 10.1016/j.jacr.2017.01.028. Review.

PMID:
28473081
29.

ACR Appropriateness Criteria® Palpable Breast Masses.

Expert Panel on Breast Imaging:, Moy L, Heller SL, Bailey L, D'Orsi C, DiFlorio RM, Green ED, Holbrook AI, Lee SJ, Lourenco AP, Mainiero MB, Sepulveda KA, Slanetz PJ, Trikha S, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 May;14(5S):S203-S224. doi: 10.1016/j.jacr.2017.02.033. Review.

PMID:
28473077
30.

ACR Appropriateness Criteria® Evaluation of Nipple Discharge.

Expert Panel on Breast Imaging:, Lee SJ, Trikha S, Moy L, Baron P, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lewin AA, Lourenco AP, Niell BL, Slanetz PJ, Stuckey AR, Vincoff NS, Weinstein SP, Yepes MM, Newell MS.

J Am Coll Radiol. 2017 May;14(5S):S138-S153. doi: 10.1016/j.jacr.2017.01.030. Review.

PMID:
28473070
31.

Compressed Sensing for Breast MRI: Resolving the Trade-Off Between Spatial and Temporal Resolution.

Vreemann S, Rodriguez-Ruiz A, Nickel D, Heacock L, Appelman L, van Zelst J, Karssemeijer N, Weiland E, Maas M, Moy L, Kiefer B, Mann RM.

Invest Radiol. 2017 Oct;52(10):574-582. doi: 10.1097/RLI.0000000000000384.

PMID:
28463932
32.

Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.

Clarke CA, Canchola AJ, Moy LM, Neuhausen SL, Chung NT, Lacey JV Jr, Bernstein L.

Breast Cancer Res. 2017 May 1;19(1):52. doi: 10.1186/s13058-017-0840-7.

33.

Breast PET/MR Imaging.

Melsaether A, Moy L.

Radiol Clin North Am. 2017 May;55(3):579-589. doi: 10.1016/j.rcl.2016.12.011. Epub 2017 Feb 1. Review.

PMID:
28411681
34.

Improvement of Atrophic Acne Scars in Skin of Color Using Topical Synthetic Epidermal Growth Factor (EGF) Serum: A Pilot Study.

Stoddard MA, Herrmann J, Moy L, Moy R.

J Drugs Dermatol. 2017 Apr 1;16(4):322-326.

PMID:
28403265
35.

Comprehensive Dynamic Contrast-Enhanced 3D Magnetic Resonance Imaging of the Breast With Fat/Water Separation and High Spatiotemporal Resolution Using Radial Sampling, Compressed Sensing, and Parallel Imaging.

Benkert T, Block KT, Heller S, Moccaldi M, Sodickson DK, Kim SG, Moy L.

Invest Radiol. 2017 Oct;52(10):583-589. doi: 10.1097/RLI.0000000000000375.

PMID:
28398929
36.

Patient and primary care provider attitudes and adherence towards lung cancer screening at an academic medical center.

Duong DK, Shariff-Marco S, Cheng I, Naemi H, Moy LM, Haile R, Singh B, Leung A, Hsing A, Nair VS.

Prev Med Rep. 2017 Jan 26;6:17-22. doi: 10.1016/j.pmedr.2017.01.012. eCollection 2017 Jun.

37.

Digital Breast Tomosynthesis Practice Patterns Following 2011 FDA Approval: A Survey of Breast Imaging Radiologists.

Gao Y, Babb JS, Toth HK, Moy L, Heller SL.

Acad Radiol. 2017 Aug;24(8):947-953. doi: 10.1016/j.acra.2016.12.011. Epub 2017 Feb 7.

PMID:
28188043
38.

Hydronephrosis Presenting 6 Months After Sacral Colpopexy: Case Report and Literature Review.

Weber LeBrun E, Santamaria E, Moy L.

Female Pelvic Med Reconstr Surg. 2017 May/Jun;23(3):e19-e21. doi: 10.1097/SPV.0000000000000398. Review.

PMID:
28145916
39.

Magnetic Resonance Imaging-Directed Ultrasound Imaging of Non-Mass Enhancement in the Breast: Outcomes and Frequency of Malignancy.

Newburg AR, Chhor CM, Young Lin LL, Heller SL, Gillman J, Toth HK, Moy L.

J Ultrasound Med. 2017 Mar;36(3):493-504. doi: 10.7863/ultra.16.03001. Epub 2017 Jan 21.

PMID:
28108994
40.

Delineating Extramammary Findings at Breast MR Imaging.

Gao Y, Ibidapo O, Toth HK, Moy L.

Radiographics. 2017 Jan-Feb;37(1):10-31. doi: 10.1148/rg.2017160051. Review.

PMID:
28076009
41.

Comparison of conventional DCE-MRI and a novel golden-angle radial multicoil compressed sensing method for the evaluation of breast lesion conspicuity.

Heacock L, Gao Y, Heller SL, Melsaether AN, Babb JS, Block TK, Otazo R, Kim SG, Moy L.

J Magn Reson Imaging. 2017 Jun;45(6):1746-1752. doi: 10.1002/jmri.25530. Epub 2016 Nov 17.

42.

ACR Appropriateness Criteria Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.

Moy L, Newell MS, Mahoney MC, Bailey L, Barke LD, Carkaci S, D'Orsi C, Goyal S, Haffty BG, Harvey JA, Hayes MK, Jokich PM, Lee SJ, Mainiero MB, Mankoff DA, Patel SB, Yepes MM.

J Am Coll Radiol. 2016 Nov;13(11S):e43-e52. doi: 10.1016/j.jacr.2016.09.023. Review.

PMID:
27814823
43.

Radiologic-Pathologic Discordance and Outcome After MRI-Guided Vacuum-Assisted Biopsy.

Lewin AA, Heller SL, Jaglan S, Elias K, Newburg A, Melsaether A, Moy L.

AJR Am J Roentgenol. 2017 Jan;208(1):W17-W22. doi: 10.2214/AJR.16.16404. Epub 2016 Oct 27.

PMID:
27786559
44.

Voxelwise analysis of simultaneously acquired and spatially correlated 18 F-fluorodeoxyglucose (FDG)-PET and intravoxel incoherent motion metrics in breast cancer.

Ostenson J, Pujara AC, Mikheev A, Moy L, Kim SG, Melsaether AN, Jhaveri K, Adams S, Faul D, Glielmi C, Geppert C, Feiweier T, Jackson K, Cho GY, Boada FE, Sigmund EE.

Magn Reson Med. 2017 Sep;78(3):1147-1156. doi: 10.1002/mrm.26505. Epub 2016 Oct 25.

PMID:
27779790
45.

Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.

Kim SG, Freed M, Leite APK, Zhang J, Seuss C, Moy L.

J Magn Reson Imaging. 2017 May;45(5):1385-1393. doi: 10.1002/jmri.25501. Epub 2016 Oct 20.

46.

Colitis as the Sole Initial Presentation of Chronic Granulomatous Disease: Histopathologic Clues to Diagnosis.

Rosenbaum BE, Shenoy R, Vuppula S, Thomas K, Moy L, Kaul A.

Pediatr Infect Dis J. 2016 Nov;35(11):1229-1231.

PMID:
27331854
47.

Public Reporting of Hospital-Level Cancer Surgical Volumes in California: An Opportunity to Inform Decision Making and Improve Quality.

Clarke CA, Asch SM, Baker L, Bilimoria K, Dudley RA, Fong N, Holliday-Hanson ML, Hopkins DS, Imholz EM, Malin J, Moy L, O'Sullivan M, Parker JP, Saigal CS, Spurlock B, Teleki S, Zingmond D, Lang L.

J Oncol Pract. 2016 Oct;12(10):e944-e948.

PMID:
27601510
48.

The relationship of obesity, mammographic breast density, and magnetic resonance imaging in patients with breast cancer.

Gillman J, Chun J, Schwartz S, Schnabel F, Moy L.

Clin Imaging. 2016 Nov - Dec;40(6):1167-1172. doi: 10.1016/j.clinimag.2016.08.009. Epub 2016 Aug 12.

PMID:
27572282
49.

Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population.

Tao L, Chu L, Wang LI, Moy L, Brammer M, Song C, Green M, Kurian AW, Gomez SL, Clarke CA.

Cancer Causes Control. 2016 Sep;27(9):1127-38. doi: 10.1007/s10552-016-0791-9. Epub 2016 Aug 5.

PMID:
27496200
50.

Stimulated echo diffusion tensor imaging (STEAM-DTI) with varying diffusion times as a probe of breast tissue.

Teruel JR, Cho GY, Moccaldi Rt M, Goa PE, Bathen TF, Feiweier T, Kim SG, Moy L, Sigmund EE.

J Magn Reson Imaging. 2017 Jan;45(1):84-93. doi: 10.1002/jmri.25376. Epub 2016 Jul 21.

PMID:
27441890

Supplemental Content

Support Center